The independent platform for news, articles and advice for professionals in laboratory medicine

Introducing a new disruptive T-cell test

As the SARS-CoV-2 pandemic continues to cause concerns, with new variants spreading worldwide, it is now widely recognised that there must be a move beyond a ‘test & trace’ only approach.

World leaders and health institutions aim to achieve high immunity rates among the population, facing the unprecedented challenge of a worldwide vaccination campaign against an emerging virus, for which no vaccine existed until a year ago.

"Alongside our genetic tests to detect SARS-CoV-2 anywhere, and at any time, we knew that we had to put our knowledge at the service of vaccination campaigns even further, leveraging the versatility of our AI platform to deliver a new kind of immunology test," said Stefano Lo Priore, founder and CEO at Hyris, a global biotechnology company renowned for its innovative and inclusive approach to genetic analysis. Hyris offers a wide range of solutions to support the fight against COVID-19 worldwide. Several medical professionals and decision-makers have already made use of the Hyris System to detect the presence of all the main Variants of Concern.

As a key part of a long-term strategy to fight COVID-19, Hyris continues to support immunology research, with the presentation of its new test to detect the body's T-cell immune response to SARS-CoV-2 recently at ‘A-WISH’, Alicante-Winter Immunology Symposium in Health.

Organised by the Spanish Society of Immunology (SEI) and the University of Alicante (UA), the A-WISH symposium promoted the advancement of the study of immunology, infectious diseases and vaccinology, as well as life and health sciences. This first edition specifically aimed to address strategies for the COVID-19 response and pandemic preparedness, the development of the vaccines against SARS-CoV-2, and the immunological response to infection and different COVID-19 vaccines.

www.hyris.net

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025